Last updated: 26 January 2024 at 4:57pm EST

Dr. Jeffrey M. Dayno M.D. Net Worth




The estimated Net Worth of Jeffrey M. Dayno is at least $1.31 Milión dollars as of 3 November 2022. Dr Dayno owns over 15,000 units of Harmony Biosciences stock worth over $559,200 and over the last 8 years he sold HRMY stock worth over $13,534. In addition, he makes $734,245 as Chief Medical Officer at Harmony Biosciences.

Dr D HRMY stock SEC Form 4 insiders trading

Dr has made over 12 trades of the Harmony Biosciences stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 15,000 units of HRMY stock worth $123,300 on 3 November 2022.

The largest trade he's ever made was exercising 18,200 units of Harmony Biosciences stock on 19 October 2021 worth over $149,604. On average, Dr trades about 5,134 units every 145 days since 2016. As of 3 November 2022 he still owns at least 15,000 units of Harmony Biosciences stock.

You can see the complete history of Dr Dayno stock trades at the bottom of the page.





Dr. Jeffrey M. Dayno M.D. biography

Dr. Jeffrey M. Dayno M.D. is the Chief Medical Officer at Harmony Biosciences.

What is the salary of Dr D?

As the Chief Medical Officer of Harmony Biosciences, the total compensation of Dr D at Harmony Biosciences is $734,245. There are 1 executives at Harmony Biosciences getting paid more, with John Charles Jacobs M.B.A. having the highest compensation of $933,938.



How old is Dr D?

Dr D is 64, he's been the Chief Medical Officer of Harmony Biosciences since . There are no older and 5 younger executives at Harmony Biosciences.

Insiders trading at Harmony Biosciences

Over the last 4 years, insiders at Harmony Biosciences have traded over $224,163,932 worth of Harmony Biosciences stock and bought 514,681 units worth $12,537,009 . The most active insiders traders include Holdings A/S Novo, Andreas Wicki a Antonio J. Gracias. On average, Harmony Biosciences executives and independent directors trade stock every 19 days with the average trade being worth of $2,907,691. The most recent stock trade was executed by Sandip Kapadia on 29 March 2024, trading 15,000 units of HRMY stock currently worth $559,200.



What does Harmony Biosciences do?

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.



What does Harmony Biosciences's logo look like?

Harmony Biosciences Holdings, Inc. logo

Complete history of Dr Dayno stock trades at Harmony Biosciences

Dátum
#
Spoločnosť
Človek
Trans.
Transakcia
Počet akcií Cena za akciu Celková cena Počet akcií po Zdroj
3 Nov 2022 Jeffrey M. Dayno
Prezident a CEO
Využitie opcie 15,000 $8.22 $123,300
3 Nov 2022
15,000
1 Nov 2022 Jeffrey M. Dayno
Prezident a CEO
Využitie opcie 15,000 $8.22 $123,300
1 Nov 2022
15,000
19 Oct 2021 Jeffrey M. Dayno
Prezident a CEO
Využitie opcie 18,200 $8.22 $149,604
19 Oct 2021
4,101
6 Oct 2021 Jeffrey M. Dayno
Prezident a CEO
Využitie opcie 1,800 $8.22 $14,796
6 Oct 2021
1,800
7 Sep 2021 Jeffrey M. Dayno
Prezident a CEO
Využitie opcie 10,000 $8.22 $82,200
7 Sep 2021
10,000
26 Aug 2021 Jeffrey M. Dayno
Prezident a CEO
Využitie opcie 10,000 $8.22 $82,200
26 Aug 2021
7,841
10 Aug 2021 Jeffrey M. Dayno
Prezident a CEO
Využitie opcie 9,950 $8.22 $81,789
10 Aug 2021
9,950
22 Jul 2021 Jeffrey M. Dayno
Prezident a CEO
Využitie opcie 50 $8.22 $411
22 Jul 2021
50


Harmony Biosciences executives and stock owners

Harmony Biosciences executives and other stock owners filed with the SEC include: